iCAD Launches New Initiatives Leveraging Unique Capabilities of its Robust Product Portfolio to Reduce Health Care System Pressures During the COVID-19 Pandemic
icad inc. (ICAD)
Last icad inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
icadmed.com/financial-news-and-events.html
Company Research
Source: GlobeNewswire
ProFound AI can assist radiologists in prioritizing patients for breast cancer screening and address the growing mammography backlog Xoft breast IORT offers single-fraction therapy alternative to weeks of daily radiation, reducing resources needed and minimizing patients’ risk of COVID-19 exposure NASHUA, N.H., March 23, 2020 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the launch of new initiatives to address emerging challenges hospitals are facing due to the pandemic of the coronavirus disease, or COVID-19. The Company and its portfolio of technologies supporting cancer detection and therapy continue to offer a strong value proposition and multiple benefits to clinicians and patients, which may be particularly relevant in light of the coronavirus outbreak: ProFound AI™, the first artificial intelligence (AI) software for digital breast tomosynthesis (DBT) to be FDA
Show less
Read more
Impact Snapshot
Event Time:
ICAD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ICAD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ICAD alerts
High impacting icad inc. news events
Weekly update
A roundup of the hottest topics
ICAD
News
- iCAD, Inc. (NASDAQ: ICAD) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.MarketBeat
- iCAD, Inc. (NASDAQ: ICAD) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.MarketBeat
- iCAD Reports Financial Results for Third Quarter Ended September 30, 2024GlobeNewswire
- iCAD's ProFound Detection Version 4.0 Gains FDA ClearanceGlobeNewswire
- iCAD to Attend 15th Annual Craig-Hallum Alpha Select ConferenceGlobeNewswire
ICAD
Sec Filings
- 11/14/24 - Form 10-Q
- 11/13/24 - Form 8-K
- ICAD's page on the SEC website